We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 24, 2020

Superior Outcomes With Biodegradable vs Second-Generation Durable Polymer Drug-Eluting Stents

JACC: Cardiovascular interventions


Additional Info

JACC: Cardiovascular interventions
Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction
JACC Cardiovasc Interv 2020 Jan 13;13(1)97-111, JC Choe, KS Cha, JG Lee, J Kim, JY Shin, J Ahn, JS Park, HW Lee, JH Oh, JH Choi, HC Lee, TJ Hong, MH Jeong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading